Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences: Selective literature review
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Background: Hyperprolactinaemia has for decades been an inevitable and neglected side-effect of antipsychotic medication. The recent introduction of prolactin-sparing antipsychotic agents makes a re-examination of this problem timely. Aims: To review the literature on antipsychotic-induced hyperprolactinaemia and its consequences. Method: A search was made of the Medline database (1966–2002) for key articles, supplemented by cross-referencing. Results: During antipsychotic treatment prolactin concentrations can rise to ten times normal levels or above, and existing data indicate that 17–78% of female patients have amenorrhoea with or without galactorrhoea. Survey data, however, suggest that clinicians underestimate the prevalence of these conditions. Long-term consequences of antipsychotic-related hypo-oestrogenism require further research but are likely to include premature bone loss. Conclusions: Antipsychotic-induced hyperprolactinaemia should become a focus of interest in the drug treatment of psychiatric patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bole-Feysot, C., Goffin, V., Edery, M., Binart, N., & Kelly, P. A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0334 · Cited by 1,938 · cited 1×
“Binding sites for prolactin are widely distributed in the body and several hundred different actions have been described, at least in vertebrate animals (Bole-Feysot et al, 1998).”
Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140 · cited 1×
“These include a relative limbic selectivity of these agents, a separation of dose and response between pharmacological functions, interactions with neurotransmitter receptors other than D2, and the binding dynamics at the D2 receptor (Kapur & Seeman, 2001).”
Parfitt, A. M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550303 · Cited by 1,001 · cited 1×
“It has been estimated that in humans as much as 25% of trabecular bone and 3% of cortical bone are resorbed and replaced each year (Parfitt, 1994).”
Arvanitis, L. A., & Miller, B. G. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00190-x · Cited by 803
Peuskens, J. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.6.712 · Cited by 551 · cited 1×
“The latter method was used in an earlier report for a subgroup of the same study population (Peuskens, 1995).”
Neurotransmitter regulation of anterior pituitary hormones.
Tuomisto, J., & Männistö, P. T. (1985) · PubMed · Cited by 531
Quetiapine in Patients With Schizophrenia: A High- and Low-Dose Double-blind Comparison With Placebo
Small, J. G. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180067009 · Cited by 478
The Bone Density of Female Twins Discordant for Tobacco Use
Hopper, J. L., & Seeman, E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402103300603 · Cited by 392
Prolactin Levels and Adverse Events in Patients Treated with Risperidone
Kleinberg, D. L., Davis, J. M., de Coster, R., Van Baelen, B., & Brecher, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00011 · Cited by 307 · cited 3×
“The low rate of galactorrhoea in the study by Kleinberg et al (1999) – 2.4% in women treated with risperidone and 2.2% in women treated with haloperidol – may be an underestimate for the same reasons as described for the analysis of amenorrhoea.”
InfluentialThe Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients
Meltzer, H. Y. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030003001 · Cited by 294
Neuroendocrine Pharmacology of Serotonergic (5-HT) Neurons
Van de Kar, L. D. (1991) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.31.040191.001445 · Cited by 240
David, S. R., Taylor, C. C., Kinon, B. J., & Breier, A. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80086-7 · Cited by 237 · cited 1×
“Whether risperidone has a greater effect on prolactin secretion than equivalent doses of haloperidol, as reported in a small 54-week continuation study (David et al, 2000), requires further study.”
Neuroleptics : neurochemical, behavioral, and clinical perspectives
Coyle, J. T., & Enna, S. J. (1983) · Raven Press eBooks · Cited by 231
Sexual Dysfunction and Plasma Prolactin Levels in Neuroleptic-treated Schizophrenic Outpatients
GHADIRIAN, A. M., CHOUINARD, G., & ANNABLE, L. (1982) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198208000-00004 · Cited by 224
Breier, A. F., Malhotra, A. K., Su, T.-P., Pinals, D. A., Elman, I., Adler, C. M., Lafargue, R. T., Clifton, A., & Pickar, D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.294 · Cited by 208 · cited 1×
“In another study Breier et al (1999) measured prolactin levels in 29 men and women with chronic schizophrenia after a 2-week standardising therapy with oral fluphenazine (20 mg daily) and 6 weeks after switching to clozapine (mean dose 400 mg daily) or risperidone (mean dose 6 mg daily).”
Increase in Bone Mass after Treatment of Hyperprolactinemic Amenorrhea
Klibanski, A., & Greenspan, S. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150903 · Cited by 205
The Effects of Antipsychotic-Induced Hyperprolactinaemia on the Hypothalamic-Pituitary-Gonadal Axis
Smith, S., Wheeler, M. J., Murray, R., & O’Keane, V. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00002 · Cited by 202
Decreased Bone Mineral Density in Medicated Psychiatric Patients
Halbreich, U., Rojansky, N., Palter, S., Hreshchyshyn, M., Kreeger, J., Bakhai, Y., & Rosan, R. (1995) · Psychosomatic Medicine · doi:10.1097/00006842-199509000-00011 · Cited by 192 · cited 1×
“Halbreich et al (1995) found significantly reduced BMD values in the lumbar spine in a group of women treated with antipsychotic, antidepressant and mood-stabilising medication, either alone or in combination.”
Crawford, A. M. K., Beasley, C. M., & Tollefson, G. D. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00036-4 · Cited by 186
Effect of clozapine on human serum prolactin levels
(1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.12.1550 · Cited by 171 · cited 1×
“Clozapine, quetiapine and olanzapine are reported either to cause no increase in prolactin secretion at all or to increase it only transiently and mildly (Meltzer et al, 1979; Small et al, 1997; Tollefson & Kuntz, 1999).”
Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia
Rao, M. L., Gross, G., Strebel, B., Halaris, A., Huber, G., Bräunig, P., & Marler, M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91147-9 · Cited by 154 · cited 1×
“In drug-free patients with acute or chronic major psychiatric disorders prolactin secretory patterns measured throughout the day are no different from those in normal controls (Linkowski et al, 1989; Rao et al, 1994).”
Beumont, P. J. V., Gelder, M. G., Friesen, H. G., Harris, G. W., MacKinnon, P. C. B., Mandelbrote, B. M., & Wiles, D. W. (1974) · British Journal of Psychiatry · doi:10.1192/bjp.124.5.413 · Cited by 136 · cited 1×
“Binding sites for prolactin are widely distributed in the body and several hundred different actions have been described, at least in vertebrate animals (Bole-Feysot et al, 1998).”
DE RIVERA, J. L., LAL, S., ETTIGI, P., HONTELA, S., MULLER, H. F., & FRIESEN, H. G. (1976) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1976.tb01953.x · Cited by 125 · cited 1×
“A partial tolerance may occur during chronic treatment (Brown & Laughren, 1981) although patients treated for several years still have significantly higher baseline prolactin levels than untreated healthy controls (Rivera et al, 1976; Zelaschi et al, 1996).”
VELDHUIS, J. D., & JOHNSON, M. L. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-1-116 · Cited by 125 · cited 1×
“The mean pulse amplitude above the preceding nadir is on average about 20–30% of the upper normal value (Veldhuis & Johnson, 1988).”
Antipsychotics: impact on prolactin levels
Goodnick, P. J., Santana, O., & Rodriguez, L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.10.1381 · Cited by 121 · cited 1×
“Trial data are limited but indicate little effect on prolactin levels (Goodnick et al, 2002).”
Subjective utility ratings of neuroleptics in treating schizophrenia
Finn, S. E., Bailey, J. M., Schultz, R. T., & Faber, R. (1990) · Psychological Medicine · doi:10.1017/s0033291700036539 · Cited by 120 · cited 1×
“In another study patients rated drug-induced sexual dysfunction as more ‘bothersome’ than most psychiatric symptoms of their illness (Finn et al, 1990).”
Turkington, R. W. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.130.3.349 · Cited by 117
Forearm and Vertebral Bone Mineral in Treated and Untreated Hyperprolactinemic Amenorrhea*
SCHLECHTE, J., EL-KHOURY, G., KATHOL, M., & WALKNER, L. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-1021 · Cited by 105
Canuso, C. M., Goldstein, J. M., Wojcik, J., Dawson, R., Brandman, D., Klibanski, A., Schildkraut, J. J., & Green, A. I. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00123-3 · Cited by 104 · cited 1×
“In two other studies (Bergemann, 2001; Canuso et al, 2002) some women with schizophrenia treated with prolactinsparing antipsychotic agents also showed evidence of ovarian dysfunction.”
Vertebral Body Bone Mineral Content in Hyperprolactinemic Women
KOPPELMAN, M. C. S., KURTZ, D. W., MORRISH, K. A., BOU, E., SUSSER, J. K., SHAPIRO, J. R., & LORIAUX, D. L. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-6-1050 · Cited by 93
Antidepressant-Induced Hyperprolactinaemia: Incidence, Mechanisms and Management
Coker, F., & Taylor, D. M. (2010) · CNS Drugs · doi:10.2165/11533140-000000000-00000 · Cited by 83
A STUDY OF SERUM PROLACTIN LEVELS IN SCHIZOPHRENIA: COMPARISON OF MALES AND FEMALES
Kuruvilla, A., Peedicayil, J., Srikrishna, G., Kuruvilla, K., & Kanagasabapathy, A. S. (1992) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1992.tb00511.x · Cited by 81
Psychological distress in patients with hyperprolactinaemia
Reavley, S., Fisher, A. D., Owen, D., Creed, F. H., & Davis, J. R. E. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2701073.x · Cited by 78
Rao, M. L., Strebel, B., Halaris, A. E., Gross, G., Bräunig, P., Huber, G., & Marler, M. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02525-2 · Cited by 75 · cited 1×
“Although depression is common in schizophrenia it is unlikely to contribute to bone loss since it is not associated with alterations in hypothalamic–pituitary–adrenal function in these patients (Rao et al, 1995; Ismail et al, 1998).”
Neuroendocrine response to antipsychotics: effects of drug type and gender
Gründer, G., Wetzel, H., Schlösser, R. G. M., Anghelescu, I. G., Hillert, A., Lange, K., Hiemke, C., & Benkert, O. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00125-5 · Cited by 73
REDUCED SPINAL AND FEMORAL BONE MASS AND DERANGED BONE MINERAL METABOLISM IN CHRONIC ALCOHOLICS
(1992) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045312 · Cited by 72
Wistedt, B., Wiles, D., & Kolakowska, T. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92334-5 · Cited by 70 · cited 1×
“In the case of depot medication normalisation may take as long as 6 months (Wistedt et al, 1981).”
Windgassen, K. W., Wesselmann, U., & Mönking, S. (1996) · Neuropsychobiology · doi:10.1159/000119265 · Cited by 67 · cited 1×
“It is more likely to occur in women who have had children and are of premenopausal age (Windgassen et al, 1996).”
Review of recent clinical studies with olanzapine
Tollefson, G. D., & Kuntz, A. J. (1999) · The British Journal of Psychiatry · doi:10.1192/s0007125000293641 · Cited by 64 · cited 1×
“Clozapine, quetiapine and olanzapine are reported either to cause no increase in prolactin secretion at all or to increase it only transiently and mildly (Meltzer et al, 1979; Small et al, 1997; Tollefson & Kuntz, 1999).”
Wode‐Helgodt, B., Eneroth, P., Fyrö, B., Gullberg, B., & Sedvall, G. (1977) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1977.tb00229.x · Cited by 63 · cited 1×
“Women have significantly greater prolactin elevations than men during chronic antipsychotic treatment with equivalent doses (Wode-Helgodt et al, 1977; Kuruvilla et al, 1992; Smith et al, 2002).”
Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia
Ataya, K. M., Mercado, A., Kartaginer, J., Abbasi, A., & Moghissi, K. S. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60365-5 · Cited by 60
Relation of Plasma Prolactin to Clinical Response in Schizophrenic Patients
Gruen, P. H. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770340072008 · Cited by 58
EFFECTS OF CHLORPROMAZINE ONPITUITARY FUNCTION
Polishuk, W. Z., & KULCSAR, S. (1956) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-16-2-292 · Cited by 56
Magharious, W., GOFF, D. C., & AMICO, E. T. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(97)00137-6 · Cited by 55
Tolerance to the prolactin-elevating effect of neuroleptics
Brown, W. A., & LAUGHREN, T. P. (1981) · Psychiatry Research · doi:10.1016/0165-1781(81)90078-0 · Cited by 54
The physical consequences of depressive illness
Dinan, T. G. (1999) · BMJ · doi:10.1136/bmj.318.7187.826 · Cited by 54 · cited 1×
“In patients with major depression bone mineral densities have been reported to be reduced and it is thought that this is due to hypercortisolism and changes in cytokine activity (see Dinan, 1999).”
The 24-Hour Profile of Plasma Prolactin in Men With Major Endogenous Depressive Illness
(1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810090055009 · Cited by 51 · cited 1×
“In drug-free patients with acute or chronic major psychiatric disorders prolactin secretory patterns measured throughout the day are no different from those in normal controls (Linkowski et al, 1989; Rao et al, 1994).”
The psychogenic effects of prolactin.
Sobrinho, L. G. (1993) · PubMed · Cited by 49
Prolactin and Neuroleptic Drugs
Green, A. I., & Brown, W. A. (1988) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30442-0 · Cited by 48 · cited 1×
“Low daily dosing regimens (e.g. 200 mg chlorpromazine) can cause significant prolactin elevations (Meltzer & Fang, 1976), and levels have been reported to increase in a dose-dependent manner up to about 600 mg chlorpromazine equivalents (Meltzer et al, 1983; Green & Brown, 1988).”
Sexual Dysfunction in Patients with Hypothalamo-Pituitary Disorders
Lundberg, P. O., & Hulter, B. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211104 · Cited by 44
Risperidone and Associated Amenorrhea: A Report of 5 Cases
Kim, Y.-K., Kim, L., & Lee, M.-S. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0509 · Cited by 43 · cited 1×
“No such systematic study is recorded, but there are case reports of amenorrhoeic women with schizophrenia who resumed menstruation after the antipsychotic medication was discontinued or switched to a prolactinsparing agent (Beumont et al, 1974; Kim et al, 1999; Haddad et al, 2001).”
Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay
Mizuchi, A., Kitagawa, N., & Miyachi, Y. (1983) · Psychopharmacology · doi:10.1007/bf00427261 · Cited by 38 · cited 1×
“Because the pituitary gland lies outside this barrier, one would expect that drugs with poor brain penetrability and higher serum concentrations such as sulpiride (Mizuchi et al, 1983) would have a greater effect on pituitary prolactin secretion.”
The dexamethasone suppression test in schizophrenia
ISMAIL, K., MURRAY, R. M., WHEELER, M. J., & O'KEANE, V. (1998) · Psychological Medicine · doi:10.1017/s0033291797006521 · Cited by 37
Clinical and Neuroendocrine Effects of Zotepine - A New Neuroleptic Drug
von Bardeleben, U., Benkert, O., & Hoisboer, F. (1987) · Pharmacopsychiatry · doi:10.1055/s-2007-1017126 · Cited by 30 · cited 1×
“Preliminary evidence indicates that zotepine can also cause prolactin elevation in humans after both acute and chronic treatment (von Bardeleben et al, 1987).”
Galactorrhea: subjective response by schizophrenic patients
Wesselmann, U., & Windgassen, K. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb09758.x · Cited by 28 · cited 1×
“In women treated with conventional antipsychotic agents spontaneous galactorrhoea of varying severity has been reported to have a prevalence of 10–57% (Wesselmann & Windgassen, 1995).”
Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports
Haddad, P. M., Hellewell, J. S. E., & Wieck, A. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500408 · Cited by 26 · cited 1×
“No such systematic study is recorded, but there are case reports of amenorrhoeic women with schizophrenia who resumed menstruation after the antipsychotic medication was discontinued or switched to a prolactinsparing agent (Beumont et al, 1974; Kim et al, 1999; Haddad et al, 2001).”
Self-citationPrentice, D., & Deakin, J. F. W. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90144-t · Cited by 24
2 Neuroendocrine effects of psychotropic drugs
Checkley, S. A. (1991) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80094-1 · Cited by 23
Inhibition of lactation by a long-acting bromocriptine.
Peters, F., Del Pozo, E., Conti, A. M. F., & Breckwoldt, M. (1986) · PubMed · Cited by 16
Psychiatric drugs and sexuality
Barnes, T. R. E. (1993) · Oxford University Press eBooks · doi:10.1093/oso/9780192622839.003.0009 · Cited by 16
High plasma prolactin levels after long-term neuroleptic treatment
Zelaschi, N. M., Delucchi, G. A., & Rodríguez, J. L. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00589-7 · Cited by 15
Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women.
Oseko, F., Morikawa, K., Motohashi, T., & Aso, T. (1988) · PubMed · Cited by 10
Cited by
Antipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management
Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634
Self-citationMeaney, A. M., Smith, S., Howes, O. D., O'Brien, M., Murray, R. M., & O'Keane, V. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.503 · Cited by 217
Byerly, M., Suppes, T., Tran, Q.-V., & Baker, R. A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815ac4e5 · Cited by 153
“that prolactin levels in antipsychotic-naive patients with schizophrenia or bipolar spectrum disorders appear to be comparable with those observed in the general population.(13) Elevated prolactin levels in patients receiving antipsychotic medications are therefore likely to be attributable to the medication rather th…”
ResultCohrs, S., Röher, C., Jordan, W., Meier, A., Huether, G., Wuttke, W., Rüther, E., & Rodenbeck, A. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0279-x · Cited by 141
Risk of hip/femur fractures in patients using antipsychotics
Hugenholtz, G. W. K., Heerdink, E. R., van Staa, T. P., Nolen, W. A., & Egberts, A. C. G. (2005) · Bone · doi:10.1016/j.bone.2005.07.005 · Cited by 77
“Which is probably caused by the effect of antipsychotics on decreasing bone mineralization, leading to weaker bones [3,5,12,21,25,39].”
Background
Metadata
- Authors
- Wieck, A., & Haddad, P. M.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2003-03
- Volume
- 182
- Issue
- 3
- Pages
- 199-204
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W1973003196
- Cited by
- 167
- References
- 62
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.